NDC 60219-2033-01 - Carbidopa and Levodopa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60219-2033
- Requested NDC
- 60219-2033-01
- Package NDCs from labels
- 60219-2033-3, 60219-2033-1, 60219-2033-5, 60219-2033-01
- Manufacturer
- Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited
- Effective date
- 2026-03-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa - Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2026-03-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60219-2033-1 | Carbidopa and Levodopa | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 2 | |
| 60219-2033-3 | Carbidopa and Levodopa | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 | |
| 60219-2033-5 | Carbidopa and Levodopa | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60219-2033 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS NY LLC] | 2 | Current NDC, Legacy NDC, 3 package rows | 20230117_0eb24333-3c11-41dd-888d-3a30d3c9d188.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60219-2033-1 | EA - Each | 60219-2033 | 07737bbf-ff2b-4012-bb7b-b5379bf8f3f0 | 1 | 2023-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Rising Pharma Holdings, Inc. | 302bfe03-d222-4a87-80ff-f2dbfb9a07f4 | 2026-01-27 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Inbrija | LEVODOPA | Merz Pharmaceuticals, LLC | a906f8e1-6e1c-480a-8276-c01bc65dd3be | 2026-01-16 | Warnings, Adverse reactions | 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | AvKARE | e232e055-7892-3541-e053-2995a90a1e74 | 2026-01-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | AvKARE | da471cd4-dcee-b026-e053-2a95a90a3d81 | 2026-01-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | AvKARE | 11e706c4-433c-1ea6-e063-6294a90ad360 | 2026-01-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| L-Dopa 1514 | L-DOPA | Professional Complementary Health Formulas | fd88cb05-2621-4582-80bf-02cf14519100 | 2026-01-08 | Warnings | 46627O600J |
| L-Dopa | L-DOPA | BioActive Nutritional, Inc. | bbb3deb1-82f3-4e36-bdc5-9242335e4747 | 2025-12-18 | Warnings | 46627O600J |
| Carbidopa | CARBIDOPA | Edenbridge Pharmaceuticals LLC. | 55b99f22-9eb2-4df6-9979-bc4c3af5e454 | 2025-12-17 | Warnings, Adverse reactions | MNX7R8C5VO |
| High Vitality Tab | AGNUS CASTUS, AMBRA GRISEA, ESTRADIOL, L-DOPA, MELATONIN, PETROSELINUM SATIVUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, SARCOLACTICUM ACIDUM, UBIDECARENONUM, BARYTA CARBONICA, CONIUM MACULATUM, SELENIUM METALLICUM, FOLLICULINUM, TESTOSTERONE, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HYPOTHALAMUS SUIS, LYMPH NODE (SUIS), MEDULLA OSSIS SUIS, OOPHORINUM (SUIS), ORCHITINUM (SUIS), PANCREAS SUIS, SPLEEN (SUIS), PROTEUS (MORGANI) | Deseret Biologicals | d13cfd09-8f8d-4b39-b60e-0e7886af2a56 | 2025-12-11 | Warnings | 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 43ce5061-0830-6f4f-e063-6394a90afc59 | 2025-11-17 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Zydus Pharmaceuticals USA Inc. | 74e7f96b-de31-4e3c-b32d-11421b291d4e | 2025-11-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | American Health Packaging | a62ae74d-6677-459c-b338-00e6851a1e00 | 2025-11-13 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Accord Healthcare, Inc. | 5217a6ec-cc26-4acc-b2da-17f6545c3b60 | 2025-10-08 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | American Health Packaging | dd2215a9-ee0f-443a-a2e3-3d0578c8cd8f | 2025-07-28 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Institutional Inc. | 16f9e4d1-6953-4d4f-b4cf-ad95a856ac25 | 2025-07-18 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | Bryant Ranch Prepack | c3f17bad-f486-4529-90df-5fdab3cb1d0b | 2025-06-04 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Bryant Ranch Prepack | 998f805d-da97-484e-a931-e409e8b8c65a | 2025-04-07 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 2d9469ba-02b2-0cfc-e063-6394a90a6292 | 2025-02-07 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 2cdca970-f077-3a80-e063-6294a90ab335 | 2025-01-29 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | A-S Medication Solutions | ea1dd532-9fb3-47c2-863c-b288ca7bb24e | 2025-01-22 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.